4-148079799-C-CTCTA
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_000901.5(NR3C2):c.*1544_*1545insTAGA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00713 in 152,242 control chromosomes in the GnomAD database, including 11 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0071 ( 11 hom., cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
NR3C2
NM_000901.5 3_prime_UTR
NM_000901.5 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.700
Genes affected
NR3C2 (HGNC:7979): (nuclear receptor subfamily 3 group C member 2) This gene encodes the mineralocorticoid receptor, which mediates aldosterone actions on salt and water balance within restricted target cells. The protein functions as a ligand-dependent transcription factor that binds to mineralocorticoid response elements in order to transactivate target genes. Mutations in this gene cause autosomal dominant pseudohypoaldosteronism type I, a disorder characterized by urinary salt wasting. Defects in this gene are also associated with early onset hypertension with severe exacerbation in pregnancy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 4-148079799-C-CTCTA is Benign according to our data. Variant chr4-148079799-C-CTCTA is described in ClinVar as [Likely_benign]. Clinvar id is 347688.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00713 (1085/152242) while in subpopulation AFR AF= 0.0237 (983/41550). AF 95% confidence interval is 0.0224. There are 11 homozygotes in gnomad4. There are 532 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1085 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NR3C2 | NM_000901.5 | c.*1544_*1545insTAGA | 3_prime_UTR_variant | 9/9 | ENST00000358102.8 | NP_000892.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NR3C2 | ENST00000358102.8 | c.*1544_*1545insTAGA | 3_prime_UTR_variant | 9/9 | 1 | NM_000901.5 | ENSP00000350815 | P4 | ||
NR3C2 | ENST00000344721.8 | c.*1544_*1545insTAGA | 3_prime_UTR_variant | 9/9 | 5 | ENSP00000341390 | P4 | |||
NR3C2 | ENST00000625323.2 | c.*1544_*1545insTAGA | 3_prime_UTR_variant | 9/9 | 5 | ENSP00000486719 | A1 |
Frequencies
GnomAD3 genomes AF: 0.00706 AC: 1074AN: 152124Hom.: 11 Cov.: 33
GnomAD3 genomes
AF:
AC:
1074
AN:
152124
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 432Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 264
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
432
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
264
Gnomad4 EAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00713 AC: 1085AN: 152242Hom.: 11 Cov.: 33 AF XY: 0.00715 AC XY: 532AN XY: 74426
GnomAD4 genome
AF:
AC:
1085
AN:
152242
Hom.:
Cov.:
33
AF XY:
AC XY:
532
AN XY:
74426
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Autosomal dominant pseudohypoaldosteronism type 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at